Hiroaki Miyata

Department of Health Quality Assessment, The University of Tokyo Graduate School of Medicine, Japan

Poster(s):

• (83) Comparative Effectiveness of First-Line SGLT2 Inhibitor Use on Heart Failure Hospitalization Among Patients with Type 2 Diabetes Mellitus; A Target Trial Emulation
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST